Review Article
Long Noncoding RNAs and Circular RNAs in the Metabolic Reprogramming of Lung Cancer: Functions, Mechanisms, and Clinical Potential
Table 1
List of lncRNAs and circRNAs that participate in lung cancer metabolic reprogramming.
| Metabolism | lncRNA/circRNA | Deregulation | Target miRNA | Downstream component | Function | Reference |
| Glucose metabolism | ARHGAP10 | ↑ | miR-150-5p | GLUT1 | Enhances Warburg effect | [19] | circMYLK | ↑ | miR-195-5p | GLUT3 | Enhances Warburg effect | [20] | circ_0008928 | ↑ | miR-488 | HK2 | Enhances Warburg effect | [21] | DUXAP8 | ↑ | miR-409-3p | HK2, LDHA | Enhances Warburg effect | [22] | IGFBP4-1 | ↑ | — | HK2, LDHA, PDK1 | Enhances Warburg effect | [23] | circMAGI3 | ↑ | miR-515-5p | HDGF | Enhances Warburg effect | [24] | BCYRN1 | ↑ | miR-149 | PKM2 | Enhances Warburg effect | [25] | AC020978 | ↑ | — | PKM2, HIF-1α | Enhances Warburg effect | [26] | KIMAT1 | ↑ | — | LDHB | Enhances Warburg effect | [27] | CRYBG3 | ↑ | — | LDHA | Enhances Warburg effect | [28] | circAGFG1 | ↑ | miR-28-5p | HIF-1α | Enhances Warburg effect | [29] | circSLC25A16 | ↑ | miR-488-3p | HIF-1α | Enhances Warburg effect | [30] | LINC01123 | ↑ | miR-199a-5p | c-Myc | Enhances Warburg effect | [31] | circ-MEMO1 | ↑ | miR-101-3p | KRAS | Enhances Warburg effect | [32] | HOXA11-AS | ↑ | miR-3619-5p | SALL4 | Enhances Warburg effect | [33] | LINC00243 | ↑ | miR-507 | PDK4 | Enhances Warburg effect | [34] | ABHD11-AS1 | ↑ | — | KLF4 | Enhances Warburg effect | [35] | AL355338 | ↑ | — | ENO1 | Enhances Warburg effect | [36] | HOTAIRM1 | ↑ | miR-498 | ABCE1 | Enhances Warburg effect | [37] | LINC01537 | ↓ | — | PDE2A | Inhibits aerobic glycolysis | [38] | circDCUN1D4 | ↓ | — | TXNIP | Inhibits aerobic glycolysis | [39] | circ-ERBB2 | ↑ | miR-7-5p | FOXM1 | Enhances Warburg effect | [40] | circTADA2A | ↑ | miR-455-3p | FOXM1 | Enhances Warburg effect | [41] | circ-PGC | ↑ | miR-532-3p | FOXR2 | Enhances Warburg effect | [42] | circPUM1 | ↑ | miR-590-5p | METTL3 | Enhances Warburg effect | [43] | circ_0000517 | ↑ | miR-330-5p | YY1 | Enhances Warburg effect | [44] | circ-PITX1 | ↑ | miR-1248 | CCND2 | Enhances Warburg effect | [45] | circ_0006677 | ↓ | miR-578 | SOCS2 | Inhibits aerobic glycolysis | [46] | circNFIX | ↑ | miR-212-3p | ADAM10 | Enhances Warburg effect | [47] | circ-ENO1 | ↑ | miR-22-3p | ENO1 | Enhances Warburg effect | [48] |
| Lipid metabolism | CTD-2245E15.3 | ↑ | — | ACC1, PC | Enhances fatty acid synthesis and anaplerosis | [49] | CCAT1 | ↑ | — | FAS, ACC1, ACOX1, PDK1, CD36, VEGFA, and PI3K/AKT/mTOR signaling pathway | Enhances fatty acid synthesis | [50] |
| Glutamine metabolism | PVT1-5 | ↑ | miR-126 | SLC7A5 | Promotes cell proliferation | [51] | circ-LDLRAD3 | ↑ | miR-137 | SLC1A5 | Promotes cell proliferation and mobility and supresses apoptosis | [52] | MINCR | ↑ | miR-126 | SLC7A5 | Promotes cell proliferation and migration and suppresses apoptosis | [53] | hsa_circRNA_103809 | ↑ | miR-377-3p | GOT1 | Increases cisplatin resistance | [54] | circ_0003028 | ↑ | miR-1298-5p | GOT2 | Promotes cell proliferation, colony formation, cell cycle progression, migration and invasion and suppresses apoptosis and autophagy | [55] |
|
|
↑: upregulated; ↓: downregulated; ACC1: acetyl-CoA carboxylase 1; ACOX1: acyl-coenzyme A oxidase 1; ADAM10: metalloprotease domain 10; CCND2: cyclin D2; circRNAs: circular RNAs; ENO1: α-enolase; FAS: fatty acid synthase; FOXM1: forkhead box M1; GOT1: glutamate oxaloacetate transaminase 1; GOT2: glutamate oxaloacetate transaminase 2; GLUT 1: glucose transporter member 1; GLUT 3: glucose transporter member 3; HDGF: hepatoma-derived growth factor; HIF-1α: hypoxia-inducible factor 1-alpha; HK2: hexokinase 2; KLF4: Krüppel-like factor 4; LDHA: lactate dehydrogenase A; LDHB: lactate dehydrogenase B; lncRNAs: long noncoding RNAs; METTL3: methyltransferase like 3; PC: pyruvate carboxylase; PDK1: pyruvate dehydrogenase kinase 1; PKM2: pyruvate kinase 2; PDK4: pyruvate dehydrogenase kinase 4; SALL4: Sal-like protein 4; SLC1A5: glutamine transporter solute carrier family A1 member 5; SLC7A5: glutamine transporter solute carrier family A7 member 5; TXNIP: thioredoxin-interacting protein; VEGFA: vascular endothelial growth factor A; YY1: Yin yang-1; ABCE1: ATP binding cassette subfamily E member 1; FOXR2: forkhead box R2; PDE2A: phosphodiesterase 2A.
|